Press Releases and News

Aphios Unveils New Corporate Website and Social Media Partnering Program
September 18, 2013
Woburn, Mass. – Aphios, a clinical stage biotechnology company developing enhanced therapeutic products for chronic, debilitating diseases and improving quality of life has launched a new and improved website, offering a fresh look, bold colors and rich content. The site restates the company's forward-thinking vision and commitment to the growing needs of the industry, patients and consumers with a focus on partnerships for the future of human health.

According to Dr. Trevor P. Castor, President and CEO, the new website will give visitors a comprehensive tour of Aphios' technologies and products. The upgraded site features a clean-cut user interface that facilitates easier navigation, increased usability and a more streamlined browsing experience. The homepage welcomes visitors with a fresh look, an aesthetic design and up-to-date news. Some of these enhancements include an interactive product pipeline, in-depth information about enabling technologies and therapeutic products, and the means of contacting us about partnerships and investing. Also new to the website is an informative video library currently featuring an overview of our prostate cancer program.

"We've added several new pages to our website in the past few months which include detailed descriptions of each of our therapeutic products, technologies and services," said Castor. "The About Us section of the site has been expanded to include profiles of the management and scientific advisory team and the Board of Directors. The Community Involvement page gives deeper insight into our commitment to serving the community." In addition, there is a wealth of call out information available on nearly every page of

"Our website is now integrated with our social media program on Facebook, LinkedIn and Twitter with current updates on product developments, scientific discoveries, and health and wellness news. We are working diligently to keep our customers updated on all aspects of our research, technologies, products, and services. We also present a number of ways for potential partners and investors to contact us directly," said Castor.


Aphios Corporation is developing green, enabling technology platforms for improving drug discovery and manufacturing, nanotechnology drug delivery, viral vaccines, and virus-free human plasma and biologics. Based on these platforms, Aphios is developing quality-of-life medicines for health maintenance and disease prevention, and enhanced therapeutics for the treatment of certain cancers and supportive care, infectious disease such as HIV, and CNS disorders such as Alzheimer's disease.